User profiles for P. Ballard
Parissa BallardWake Forest School of Medicine Verified email at wakehealth.edu Cited by 2038 |
Scientific basis and therapeutic regimens for use of antenatal glucocorticoids
PL Ballard, RA Ballard - American journal of obstetrics and gynecology, 1995 - Elsevier
The scientific basis for use of prenatal steroid therapy in preparing the human fetus for
premature delivery is extensive and convincing. Studies in numerous animal species have …
premature delivery is extensive and convincing. Studies in numerous animal species have …
Hormonal regulation of pulmonary surfactant
PL Ballard - Endocrine Reviews, 1989 - academic.oup.com
… 50 and PL Ballard, unpublished data). The physiological role of fibroblast pneumonocyte
factor, and possibly other fibroblast proteins, in regulation of surfactant awaits further …
factor, and possibly other fibroblast proteins, in regulation of surfactant awaits further …
AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer
…, MR Brewer, E Ichihara, J Sun, H Jin, P Ballard… - Cancer discovery, 2014 - AACR
First-generation EGFR tyrosine kinase inhibitors (EGFR TKI) provide significant clinical
benefit in patients with advanced EGFR-mutant (EGFRm + ) non–small cell lung cancer (NSCLC)…
benefit in patients with advanced EGFR-mutant (EGFRm + ) non–small cell lung cancer (NSCLC)…
Physical study of laser‐produced plasma in confined geometry
R Fabbro, J Fournier, P Ballard, D Devaux… - Journal of applied …, 1990 - pubs.aip.org
We study in this paper the different physical processes involved in laser‐produced plasma in
confined geometry. With this technique, a laser irradiates a target at an intensity of a few GW…
confined geometry. With this technique, a laser irradiates a target at an intensity of a few GW…
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
JW Langston, P Ballard, JW Tetrud, I Irwin - Science, 1983 - science.org
… P is the olrending agent in these patients for several reasons. First, MPTP was the major
component in the material injected by patients I ilOd 2. Second, MPTP was also present in …
component in the material injected by patients I ilOd 2. Second, MPTP was also present in …
Youth participatory approaches and health equity: Conceptualization and integrative review
There is an array of youth participatory approaches relevant to health equity efforts in
community psychology, adolescent health, youth development, and education. While they share …
community psychology, adolescent health, youth development, and education. While they share …
Preclinical comparison of osimertinib with other EGFR-TKIs in EGFR-mutant NSCLC brain metastases models, and early evidence of clinical brain metastases activity
… Relative efflux ratios of osimertinib or its metabolite AZ5104 between MDR1-MDCK and
normal MDCK cells and between BCRP-MDCK and MDCK cells suggest that these agents are P…
normal MDCK cells and between BCRP-MDCK and MDCK cells suggest that these agents are P…
Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP) Seven cases
PA Ballard, JW Tetrud, JW Langston - Neurology, 1985 - AAN Enterprises
Seven patients developed chronic and severe parkinsonism after repeatedly injecting 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP) intravenously. Levodopa and bromocriptine …
(MPTP) intravenously. Levodopa and bromocriptine …
Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptor
MRV Finlay, M Anderton, S Ashton, P Ballard… - 2014 - ACS Publications
Epidermal growth factor receptor (EGFR) inhibitors have been used clinically in the
treatment of non-small-cell lung cancer (NSCLC) patients harboring sensitizing (or activating) …
treatment of non-small-cell lung cancer (NSCLC) patients harboring sensitizing (or activating) …
[HTML][HTML] Inhaled nitric oxide in preterm infants undergoing mechanical ventilation
RA Ballard, WE Truog, A Cnaan… - … England Journal of …, 2006 - Mass Medical Soc
… in the placebo group (P=0.042). The infants who received inhaled nitric oxide were
discharged sooner (P=0.04) and received supplemental oxygen therapy for a shorter time (P=0.006). …
discharged sooner (P=0.04) and received supplemental oxygen therapy for a shorter time (P=0.006). …